Advanced glycation end-product cross-link breakers. A novel therapeutic pathway for cardiovascular disease.
Hollenberg
Norman K
NK
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. djpagecapo@rucs.bwh.harvard.edu
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D017127:Glycation End Products, Advanced / Q000737:chemistry / Q000378:metabolism*; D006801:Humans
D000959:Antihypertensive Agents; D017127:Glycation End Products, Advanced